Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124200403 | 12420040 | 3 | F | 20140325 | 20160627 | 20160531 | 20160707 | EXP | US-BAYER-2016-061111 | BAYER | 43.00 | YR | A | M | Y | 0.00000 | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124200403 | 12420040 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | UNK | Y | N | UNKNOWN;UNKNOWN | 0 | FILM-COATED TABLET | ||||||
| 124200403 | 12420040 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | Y | N | UNKNOWN;UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | QD | |||
| 124200403 | 12420040 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | Y | N | UNKNOWN;UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | QD | |||
| 124200403 | 12420040 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Y | N | 0 | FILM-COATED TABLET | |||||||||
| 124200403 | 12420040 | 5 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | QD | |||||||
| 124200403 | 12420040 | 6 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 124200403 | 12420040 | 7 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | 81 MG, QD | 999999 | 81 | MG | COATED TABLET | QD | ||||||
| 124200403 | 12420040 | 8 | SS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | 999999 | COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124200403 | 12420040 | 1 | Cerebrovascular accident prophylaxis |
| 124200403 | 12420040 | 2 | Pulmonary embolism |
| 124200403 | 12420040 | 3 | Atrial fibrillation |
| 124200403 | 12420040 | 4 | Embolism venous |
| 124200403 | 12420040 | 5 | Coronary artery disease |
| 124200403 | 12420040 | 6 | Coronary arterial stent insertion |
| 124200403 | 12420040 | 7 | Coronary artery disease |
| 124200403 | 12420040 | 8 | Coronary arterial stent insertion |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124200403 | 12420040 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124200403 | 12420040 | Anastomotic ulcer haemorrhage | |
| 124200403 | 12420040 | Haematemesis | |
| 124200403 | 12420040 | Haemorrhoidal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124200403 | 12420040 | 1 | 201310 | 0 | ||
| 124200403 | 12420040 | 2 | 201403 | 201405 | 0 | |
| 124200403 | 12420040 | 3 | 201408 | 0 | ||
| 124200403 | 12420040 | 5 | 201404 | 0 | ||
| 124200403 | 12420040 | 7 | 201404 | 0 |